• Publications
  • Influence
Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar
ABSTRACT A biosimilar product needs to demonstrate biosimilarity to the originator reference product, and the quality profile of the latter should be monitored throughout the period of theExpand
  • 57
  • 1